
1. proc natl acad sci u a. 2014 aug 5;111(31):11425-30. doi:
10.1073/pnas.1409099111. epub 2014 jul 16.

tmem129 derlin-1 associated erad e3 ligase essential virus-induced
degradation mhc-i.

van den boomen dj(1), timms rt(1), grice gl(1), stagg hr(1), sk√∏dt k(2), dougan
g(3), nathan ja(1), lehner pj(4).

author information: 
(1)cambridge institute medical research, department medicine, university
of cambridge, cambridge cb2 0xy, united kingdom;
(2)department cancer inflammation, university southern denmark, 5000
odense, denmark; and.
(3)wellcome trust sanger institute, wellcome trust genome campus, cambridge cb10 
1sa, united kingdom.
(4)cambridge institute medical research, department medicine, university
of cambridge, cambridge cb2 0xy, united kingdom; pjl30@cam.ac.uk.

the us11 gene product human cytomegalovirus promotes viral immune evasion by
hijacking endoplasmic reticulum (er)-associated degradation (erad) pathway.
us11 initiates dislocation newly translocated mhc er cytosol
for proteasome-mediated degradation. despite critical role ubiquitin in
this degradation pathway, responsible e3 ligase unknown. forward
genetic screen host erad components hijacked us11 near-haploid kbm7
cells, identified tmem129, uncharacterized polytopic membrane protein.
tmem129 essential rate-limiting us11-mediated mhc-i degradation and
acts novel er resident e3 ubiquitin ligase. tmem129 contains unusual
cysteine-only ring intrinsic e3 ligase activity recruited us11 via
derlin-1. together e2 conjugase ube2j2, tmem129 responsible the
ubiquitination, dislocation, subsequent degradation us11-associated mhc-i.
us11 engages two degradation pathways: derlin-1/tmem129-dependent pathway
required mhc-i degradation sel1l/hrd1-dependent pathway required for
"free" us11 degradation. data show tmem129 novel erad e3 ligase and
the central component novel mammalian erad complex.

doi: 10.1073/pnas.1409099111 
pmcid: pmc4128144
pmid: 25030448  [indexed medline]

